China touts electric-car maker Nio as the next Tesla
Shares in electric-car manufacturer Nio have rocketed over the past year. But can it keep motoring and live up to the hype? Matthew Partridge reports
Chinese electric-vehicle (EV) company Nio, listed in New York, has become “one of the most popularly traded stocks in Britain” because many see it as “the next Tesla” says The Times. The stock has risen 28-fold from $2.11 in March to about $60 today. Nio’s market value eclipses that of both General Motors and Ford. Nio is also endorsed by many “admired and successful technology investors” who argue that it is “probably the clear leader” among Chinese electric-car companies.
Nio’s surge marks a sharp change in fortune from last year, when it “appeared to be teetering on the edge of insolvency”, says Alison Tudor-Ackroyd in the South China Morning Post. Not only had Covid-19 “crimped” sales, but the company was also reeling from the Chinese government’s cuts in subsidies as well as the prospect of stronger competition from Tesla in its home market. However, Beijing then reversed course, with a state-controlled company making an emergency injection of cash into the company, enabling Nio to boost production. It recently unveiled a new model that claims to “go as far as 1,000 kilometres (621 miles) on a single charge”.
A rich valuation
Nio’s shares could go even higher, says Trefis Team on Forbes. Sales are “poised to double to about $5bn in 2021”. Nio will benefit from the fact that China “has set a target that 25% of car sales by 2025 must be new-energy vehicles”. It is also developing a modular battery system that will allow users to swap batteries quickly, making it easier to travel long distances, and promising an improved self-driving system. Still, its valuation looks “rich” and it is not clear that it has done enough to build “a sustainable competitive advantage”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The frenzy surrounding Nio is certainly helping it “suck up capital”, with the company announcing last week that it is issuing $1.3bn in convertible bonds, says Anjani Trivedi on Bloomberg. Still, investors need to be cautious, as the “fandom” that these shares have been enjoying is unlikely to last if they can’t deliver tangible results. Note that Nio “hasn’t been profitable since inception”. It recently admitted that “it may have to scale back operations if it can’t move into the black”. The big challenge is “less about getting people revved up for electric cars” and “more in making good, affordable vehicles – at scale”.
The Chinese EV sector looks due for a shakeout, says Christian Shepherd and Thomas Hale in the Financial Times. Around $60bn in government subsidies for EVs between 2009 and 2017 prompted “hundreds of new companies” to spring up in China. But many pocketed these sweeteners “without ever manufacturing a car”. New models by firms such as Nio and Xpeng have “invigorated” the market, but the Chinese government is so anxious about fraud and waste that Beijing is ordering local governments “to investigate land use, investment and progress of EV projects initiated since 2015”.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
British Airways revamps Avios scheme bringing down flight prices to £1
With the new Avios part-payments scheme you can now bag a British Airways flight for as little as £1
By Oojal Dhanjal Published
-
RBS to close a fifth of branches
Royal Bank of Scotland plans to shut 18 branches across Scotland, resulting in the loss of 105 jobs. We have the full list of closures.
By Ruth Emery Published
-
The industry at the heart of global technology
The semiconductor industry powers key trends such as artificial intelligence, says Rupert Hargreaves
By Rupert Hargreaves Published
-
Three emerging Asian markets to invest in
Professional investor Chetan Sehgal of Templeton Emerging Markets Investment Trust tells us where he’d put his money
By Chetan Sehgal Published
-
What to consider before investing in small-cap indexes
Small-cap index trackers show why your choice of benchmark can make a large difference to long-term returns
By Cris Sholto Heaton Published
-
Why space investments are the way to go for investors
Space investments will change our world beyond recognition, UK investors should take note
By Merryn Somerset Webb Published
-
Time to tap into Africa’s mobile money boom
Favourable demographics have put Africa on the path to growth when it comes to mobile money and digital banking
By Rupert Hargreaves Published
-
M&S is back in fashion: but how long can this success last?
M&S has exceeded expectations in the past few years, but can it keep up the momentum?
By Rupert Hargreaves Published
-
The end of China’s boom
Like the US, China too got fat on fake money. Now, China's doom is not far away.
By Bill Bonner Published
-
Magic mushrooms — an investment boom or doom?
Investing in these promising medical developments might see you embark on the trip of a lifetime.
By Bruce Packard Published